STAT

Opinion: Price controls would stifle innovation in the pharmaceutical industry

Regulating drug prices might shave a few points off health care spending, but the blow to innovation would be huge.

Consumer access to affordable and effective medicines is an important issue. As the cost of many drugs continues to rise, sometimes astronomically, some have suggested imposing price controls on the U.S. pharmaceutical industry. Doing that risks crippling our only hope of curing the many serious diseases that still plague us.

The global pharmaceutical industry is among the most profitable, driven by its ability to price to value, especially in the United States. High profits attract investors and generate money for research. The global pharmaceutical industry’s investment in on research and development as a percent of sales than do the top 18 U.S. .

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readSociety
Opinion: It’s Time To Change The Definition Of ‘Health’
Rather than pursuing the "absence" of disease, we need a more inclusive definition of health — one that works for more people.
STAT4 min read
Opinion: State Drug Importation Programs Will Work With The FDA, Not Outside Of It
State programs can use the global pharmaceutical supply chain to relieve the sometimes crushing financial burden of drug treatments — at least until we have an effective national approach to…
STAT5 min read
Opinion: I Wanted To Try Medical Marijuana. Why Couldn’t My Doctors Help Me?
Until we make it easier to study the effects of #medicalmarijuana and #cannabis, and train doctors about its benefits and risks, people who could benefit from it will continue to…